Skip to content
10-Q

Quarterly Report

Dova Pharmaceuticals Inc.

0001685071-19-000029

← back to feed
Filed
Nov 12, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Nov 8, 2019 28.85M sh
Capex Q3 2019 · Sep 30, 2019 $286K
Capex Q3 2019 · Sep 30, 2018 $269K
Operating Cash Flow Q3 2019 · Sep 30, 2019 −$47.31M
Operating Cash Flow Q3 2019 · Sep 30, 2018 −$36.26M
Long Term Debt Q3 2019 · Sep 30, 2019 $28.92M
Long Term Debt Q3 2019 · Dec 31, 2018 $13.94M
Short Term Debt Q3 2019 · Sep 30, 2019 $1.91M
Short Term Debt Q3 2019 · Dec 31, 2018 $6.67M
Cash And Equivalents Q3 2019 · Sep 30, 2019 $68.45M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $104.57M
Stockholders Equity Q3 2019 · Sep 30, 2019 $33.24M
Stockholders Equity Q3 2019 · Jun 30, 2019 $50.81M
Stockholders Equity Q3 2019 · Mar 31, 2019 $63.29M
Stockholders Equity Q3 2019 · Dec 31, 2018 $76.36M
Stockholders Equity Q3 2019 · Sep 30, 2018 $94.2M
Stockholders Equity Q3 2019 · Jun 30, 2018 $109.72M
Stockholders Equity Q3 2019 · Mar 31, 2018 $125.1M
Stockholders Equity Q3 2019 · Dec 31, 2017 $61.18M
Current Liabilities Q3 2019 · Sep 30, 2019 $15.21M
Current Liabilities Q3 2019 · Dec 31, 2018 $19.5M
Total Liabilities Q3 2019 · Sep 30, 2019 $45.71M
Total Liabilities Q3 2019 · Dec 31, 2018 $35.81M
Current Assets Q3 2019 · Sep 30, 2019 $77.23M
Current Assets Q3 2019 · Dec 31, 2018 $111.81M
Total Assets Q3 2019 · Sep 30, 2019 $78.95M
Total Assets Q3 2019 · Dec 31, 2018 $112.17M
Rd Expense Q3 2019 · Sep 30, 2019 $4.19M
Rd Expense Q3 2019 · Sep 30, 2019 $12.78M
Rd Expense Q3 2019 · Sep 30, 2018 $4.85M
Rd Expense Q3 2019 · Sep 30, 2018 $12.77M
Net Income Q3 2019 · Sep 30, 2019 −$21.29M
Net Income Q3 2019 · Sep 30, 2019 −$54.73M
Net Income Q3 2019 · Jun 30, 2019 −$17.06M
Net Income Q3 2019 · Mar 31, 2019 −$16.38M
Net Income Q3 2019 · Sep 30, 2018 −$19.52M
Net Income Q3 2019 · Sep 30, 2018 −$52.95M
Net Income Q3 2019 · Jun 30, 2018 −$19.66M
Net Income Q3 2019 · Mar 31, 2018 −$13.77M
Operating Income Q3 2019 · Sep 30, 2019 −$20.67M
Operating Income Q3 2019 · Sep 30, 2019 −$53.95M
Operating Income Q3 2019 · Sep 30, 2018 −$19.32M
Operating Income Q3 2019 · Sep 30, 2018 −$52M
Revenue Q3 2019 · Sep 30, 2019 $3.37M
Revenue Q3 2019 · Sep 30, 2019 $10.89M
Revenue Q3 2019 · Sep 30, 2018 $2.93M
Revenue Q3 2019 · Sep 30, 2018 $7.51M